Gainers
- Brooklyn ImmunoTherapeutics, Inc. BTX shares gained 75.6% to settle at $43.73 on Wednesday. The company recently said it paid $1 million towards acquisition of license for mRNA technology platform to develop genetically edited cells for multiple cancers and blood disorders.
- Uxin Limited UXIN shares jumped 45.3% to close at $2.95 on Wednesday after the company reported Q3 earnings results.
- Regional Health Properties, Inc. RHE surged 44.8% to settle at $6.37.
- Galectin Therapeutics Inc. GALT rose 22.6% to close at $5.10. The company recently announced neurosurgeon Dr. Ben Carson, Sr. joined the team as a special consultant to accelerate and enhance development of the company's galectin-3 inhibitor, belapectin.
- Aurora Mobile Limited JG shares gained 19.6% to close at $4.21 on Wednesday after Oppenheimer initiated coverage on the stock with an Outperform rating and a price target of $6 per share.
- Shineco, Inc. TYHT surged 17.7% to close at $9.79.
- ClearSign Technologies Corporation CLIR surged 16.3% to close at $5.00 as the company received certification for firetube boiler burner in China.
- Vyant Bio, Inc. VYNT jumped 16% to close at $4.65. Vyant Bio, OrdaĹŤs Bio and Cellaria, recently announced collaboration to 'design and qualify biomarker-specific small protein therapeutics.'
- Enveric Biosciences, Inc. ENVB surged 15.4% to close at $2.70.
- China Green Agriculture, Inc. CGA gained 15.4% to settle at $13.68.
- Unitil Corporation UTL climbed 15.3% to settle at $57.57. Unitil will replace Waddell & Reed Financial in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
- Genworth Financial, Inc. GNW rose 15.2% to close at $4.40. Genworth Financial will replace Glu Mobile in the S&P SmallCap 600 prior to the opening of trading on Monday, May 3.
- VistaGen Therapeutics, Inc. VTGN gained 15.1% to close at $2.44.
- 22nd Century Group, Inc. XXII shares rose 14.5% to settle at $5.62.
- Century Casinos, Inc. CNTY surged 14.2% to close at $12.81 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a price target of $18 per share.
- Ault Global Holdings, Inc. DPW jumped 14% to settle at $2.85.
- Boxlight Corporation BOXL shares gained 13.9% to settle at $2.78. Maxim Group reiterated Boxlight with a Buy and announced a $6 price target.
- Mind Medicine (MindMed) Inc. MNMD climbed 13.7% to close at $4.57. Mind Medicine commenced trading its subordinate voting shares on The Nasdaq Capital Market Tuesday.
- Pitney Bowes Inc. PBI gained 13.7% to settle at $9.73.
- Haverty Furniture Companies, Inc. HVT surged 13.5% to close at $46.52 after the company reported better-than-expected Q1 results.
- U.S. Silica Holdings, Inc. SLCA gained 13.3% to settle at $13.08.
- Everi Holdings Inc. EVRI surged 12.6% to close at $17.95 after B. Riley FBR initiated coverage on the stock with a Buy rating and announced a price target of $25 per share.
- Manhattan Associates, Inc. MANH jumped 12.2% to close at $144.02 following upbeat quarterly results.
- CyberOptics Corporation CYBE surged 11.7% to close at $33.51 after the company reported better-than-expected Q1 results. The company also announced it received a new order valued at approximately $2.4 million for its mini LED inspection and metrology.
- Shopify Inc. SHOP gained 11.4% to close at $1,288.80 after the company reported better-than-expected Q1 results.
- Deutsche Bank Aktiengesellschaft DB climbed 11.1% to close at $13.72 after reporting upbeat quarterly profit.
- GSX Techedu Inc. GSX jumped 11% to settle at $35.51. The company recently reported FY20 earnings results.
- Smart Share Global Limited EM gained 8.7% to close at $9.21.
- NCR Corporation NCR gained 8.7% to close at $45.96 after the company reported better-than-expected Q1 results.
- Creatd, Inc. CRTD rose 8% to settle at $4.03 after the company reported strategic investment in Untamed Photographer, NFT Collaboration, and Vocal Community and Challenge Sponsorships.
- RiceBran Technologies RIBT gained 7.6% to close at $1.27 after jumping around 27% on Tuesday.
- Genpact Limited G rose 5.9% to close at $47.67. Genpact will replace Genworth Financial in the S&P MidCap 400 prior to the opening of trading on Monday, May 3.
- Calliditas Therapeutics AB CALT rose 4.3% to close at $30.00 after the company said the FDA has accepted the submission and granted priority review for the new drug application for Nefecon, a down regulator of IgA1 for the treatment of IgA nephropathy. The FDA has set a PDUFA goal date of Sept. 15.
- Alphabet Inc. GOOGL rose 3% to close at $2,359.04 after the company reported better-than-expected results for its first quarter and also announced a $50 billion Class C capital stock buyback program.
Check out these big penny stock gainers and losers
Losers
- Urban Tea, Inc. MYT fell 37.5% to close at $2.90 after the company reported pricing of approximately $25million registered direct offering.
- Protalix BioTherapeutics, Inc. PLX shares tumbled 32.6% to close at $3.93 on Wednesday. Protalix BioTherapeutics and partner Chiesi announced that they received a complete response letter from the FDA regarding the biologics license application, seeking accelerated approval of pegunigalsidase alfa for the proposed treatment of adult patients with Fabry disease.
- R. R. Donnelley & Sons Company RRD dipped 22.3% to close at $4.59 after the company reported worse-than-expected Q1 earnings.
- Revolution Medicines, Inc. RVMD fell 20.8% to close at $33.80.
- Atea Pharmaceuticals, Inc. AVIR fell 20.7% to settle at $26.65.
- Benitec Biopharma Inc. BNTC fell 20.6% to settle at $4.35 after the company reported that, due to demand, the underwriter has agreed to increase the size of the previously announced offering of 3.036 million shares of common stock at a price of $4.25 per share, for raising gross proceeds of $12.9 million.
- Nymox Pharmaceutical Corporation NYMX fell 15% to close at $2.09. Nymox Pharmaceutical’s director recently purchased 40,000 shares at an average price of $2.08 per share.
- Pinterest, Inc. PINS fell 14.5% to close at $66.33 after the company reported Q1 earnings results.
- Enphase Energy, Inc. ENPH fell 14.1% to close at $146.91 after the company issued weak Q2 sales guidance.
- Veoneer, Inc. VNE dipped 13.7% to close at $22.99 following downbeat quarterly sales.
- REV Group, Inc. REVG fell 12.6% to settle at $18.38.
- Reviva Pharmaceuticals Holdings, Inc. RVPH dipped 12.5% to close at $6.39. Reviva Pharmaceuticals recently announced the full details of its Phase 2 trial evaluating its lead drug candidate, RP5063 (brilaroxazine), for Acute Schizophrenia.
- Spotify Technology S.A. SPOT dropped 12.3% to close at $256.84 after the company reported Q1 earnings results.
- BioVie Inc. BIVI fell 12.2% to close at $18.88 after the company announced it acquired biopharma assets from privately held NeurMedix.
- Medley Management Inc. MDLY shares dropped 12% to settle at $5.36.
- Mammoth Energy Services, Inc. TUSK fell 10.6% to close at $3.79.
- F5 Networks, Inc. FFIV fell 9.1% to settle at $186.70 after the company reported Q2 results and issued Q3 forecast.
- Nxt-ID, Inc. NXTD fell 8.5% to close at $0.9426 after climbing around 15% on Tuesday.
- Agrify Corporation AGFY dropped 8.4% to settle at $11.26.
- AzurRx BioPharma, Inc. AZRX fell 8.3% to close at $0.9446 after jumping over 15% on Tuesday.
- Helen of Troy Limited HELE dropped 7.9% to settle at $206.08 following Q4 results.
- NetSol Technologies, Inc. NTWK fell 7.6% to settle at $4.99 potentially on profit-taking after the stock rallied roughly 35% yesterday.
- Amgen Inc. AMGN fell 7.2% to settle at $236.71 after the company reported worse-than-expected Q1 results.
- Aldeyra Therapeutics, Inc. ALDX fell 6.2% to close at $13.93 after the company reported a proposed $125 million public offering of common stock.
- Steven Madden, Ltd. SHOO fell 5.8% to close at $40.02 after the company issued Q2 guidance below analyst estimates.
- Microsoft Corporation MSFT shares fell 2.8% to close at $254.56 after the company reported Q3 earnings results.
ALDXAldeyra Therapeutics Inc
$4.982.47%
AMGNAmgen Inc
$263.380.84%
AVIRAtea Pharmaceuticals Inc
$3.191.92%
BIVIBioVie Inc
$1.94-6.73%
BNTCBenitec Biopharma Inc
$11.41-6.24%
BOXLBoxlight Corp
$0.3447-3.98%
CLIRClearSign Technologies Corp
$1.144.59%
CNTYCentury Casinos Inc
$3.738.75%
CRTDCreatd Inc
$0.4200-%
DBDeutsche Bank AG
$16.60-3.04%
EMSmart Share Global Ltd
$0.6912-3.46%
ENPHEnphase Energy Inc
$71.558.74%
ENVBEnveric Biosciences Inc
$0.32940.30%
EVRIEveri Holdings Inc
$13.49-0.07%
FFIVF5 Inc
$252.250.73%
GGenpact Ltd
$42.19-0.26%
GALTGalectin Therapeutics Inc
$1.02-49.0%
GNWGenworth Financial Inc
$7.031.01%
GOOGLAlphabet Inc
$192.792.27%
HELEHelen Of Troy Ltd
$62.781.01%
HVTHaverty Furniture Companies Inc
$21.670.37%
JGAurora Mobile Ltd
$5.88-2.87%
MANHManhattan Associates Inc
$280.26-0.81%
MNMDMind Medicine Inc
$7.162.07%
MSFTMicrosoft Corp
$437.350.07%
NTWKNETSOL Technologies Inc
$2.753.38%
PBIPitney Bowes Inc
$7.231.11%
PINSPinterest Inc
$29.56-0.17%
PLXProtalix BioTherapeutics Inc
$1.761.15%
REVGREV Group Inc
$31.78-1.03%
RHERegional Health Properties Inc
$1.510.62%
RIBTRiceBran Technologies
$0.1500-57.1%
RVMDRevolution Medicines Inc
$43.801.18%
SHOOSteven Madden Ltd
$42.830.21%
SHOPShopify Inc
$109.502.27%
SPOTSpotify Technology SA
$461.061.52%
TUSKMammoth Energy Services Inc
$2.840.71%
UTLUnitil Corp
$53.78-0.85%
UXINUxin Ltd
$3.78-%
VTGNVistagen Therapeutics Inc
$2.6015.6%
XXII22nd Century Group Inc
$5.036.34%
RVPHReviva Pharmaceuticals Holdings Inc
$1.36-9.33%
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Posted In:
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in